Group 1 - The core viewpoint of the news is that Baiao Chemical's stock price increased by 5.04% to 25.83 CNY per share, with a trading volume of 218 million CNY and a turnover rate of 1.23%, resulting in a total market capitalization of 18.242 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, is primarily engaged in the research, production, and sales of isothiazolinone-based industrial biocides [1] - The company's revenue composition shows that domestic business accounts for 66.61%, while overseas business constitutes 33.39% [1] Group 2 - Among Baiao Chemical's top ten circulating shareholders, a fund under Southern Fund, the Southern CSI 1000 ETF (512100), entered the top ten in the second quarter, holding 3.2711 million shares, which is 0.46% of the circulating shares [2] - The Southern CSI 1000 ETF (512100) was established on September 29, 2016, with a latest scale of 64.953 billion CNY, and has achieved a year-to-date return of 22.9% [2] - The fund manager, Cui Lei, has a tenure of 6 years and 307 days, with the fund's total asset scale at 94.976 billion CNY, achieving a best return of 137.42% and a worst return of -17.29% during the tenure [2]

大连百傲化学股份有限公司 2025 年第一次临时股东大会会议资料 大连百傲化学股份有限公司 2025 年第一次临时股东大会会议资料 （603360） 2025 年 09 月 1 | 2025 | 年第一次临时股东大会须知 3 | | --- | --- | | 2025 | 年第一次临时股东大会议程 5 | | 议案 | 1：关于取消监事会、变更注册资本并修订《公司章程》及其附件的议案.7 | | 议案 | 2：关于修订公司管理制度的议案 9 | | 议案 | 3：关于补选公司第五届董事会非独立董事的议案 10 | 2 大连百傲化学股份有限公司 2025 年第一次临时股东大会会议资料 大连百傲化学股份有限公司 2025 年第一次临时股东大会须知 为维护股东的合法权益，保障股东在大连百傲化学股份有限公司（以下简称 "公司"）2025 年第一次临时股东大会会议期间依法行使权利，确保股东大会的 正常秩序和议事效率，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《上市公司股东会规则》《大连百傲化学股份有限公司章程》（以下简称"《公司 章程》"）等有关规定，制定本须知。 一、各股东请按照本次股东大会会议通知 ...

Core Viewpoint - The company emphasizes that sustainable and stable shareholder returns are built on high-quality and sustainable development, focusing on core business, optimizing management, and enhancing profitability [1] Group 1: Company Overview - Dalian Bai'ao Chemical Co., Ltd. specializes in the research, production, and sales of isothiazolinone industrial biocide raw materials and has been in the industry for over 20 years, becoming the largest producer of such biocides in Asia [1] - In 2024, the company transitioned into the semiconductor equipment sector through its controlling stake in Suzhou Xinhuilian Semiconductor Technology Co., Ltd. and a stake in Xinhuilian New (Suzhou) Technology Co., Ltd., establishing a dual business model of industrial biocides and semiconductor equipment [1] Group 2: Financial Performance - In the first half of the year, the company reported revenue of 749 million yuan, a year-on-year increase of 28.42%, while net profit attributable to shareholders decreased by 44.22% to 91.79 million yuan [2] - The chemical business faced challenges due to external environmental factors, weak market demand, and continuously low prices, leading to sustained pressure on profitability [2] Group 3: Business Segments - The company’s industrial biocide products are primarily exported to Asia, Europe, the United States, and South America, with overall changes remaining stable [2] - Despite the pressure on profitability in the biocide segment, there are positive signs, such as a 7.69% increase in average sales prices of biocide products in the second quarter and a 21.37% decrease in the comprehensive procurement costs of key raw materials [2] - The semiconductor equipment business, led by the subsidiary Xinhuilian, remains a core strategic direction, focusing on technology development, market expansion, and operational stability [3]

Core Viewpoint - Baiao Chemical's stock has shown significant volatility, with a year-to-date increase of 57.66% but a recent decline of 7.48% over the past five trading days [2] Group 1: Stock Performance - As of September 5, Baiao Chemical's stock price was 24.38 CNY per share, with a market capitalization of 17.218 billion CNY [1] - The stock has experienced a 20.40% increase over the past 20 days and a 19.51% increase over the past 60 days [2] - The company has appeared on the stock market's "龙虎榜" three times this year, with the latest appearance on August 28 [2] Group 2: Financial Performance - For the first half of 2025, Baiao Chemical reported a revenue of 749 million CNY, representing a year-on-year growth of 28.42% [2] - The net profit attributable to shareholders was 91.7885 million CNY, which reflects a year-on-year decrease of 44.22% [2] Group 3: Shareholder Information - As of June 30, 2025, Baiao Chemical had 21,300 shareholders, an increase of 20.58% from the previous period [2] - The average number of circulating shares per shareholder was 33,173, up by 16.11% [2] - The company has distributed a total of 1.224 billion CNY in dividends since its A-share listing, with 722 million CNY distributed over the past three years [3] Group 4: Business Overview - Baiao Chemical, established on September 22, 2003, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [2] - The company's revenue composition is 66.61% from domestic business and 33.39% from international business [2] - Baiao Chemical is classified under the basic chemical industry, specifically in agricultural chemical products [2]

（文章来源：证券日报） 证券日报网讯 9月4日晚间，百傲化学发布公告称，截至2025年9月4日，公司通过集中竞价方式累计回 购公司股份5，365，500股，占公司总股本的比例为0.76%。 ...

格隆汇9月4日丨百傲化学(603360.SH)公布，截至2025年9月4日，公司通过集中竞价方式累计回购公司 股份5,365,500股，已回购股份占公司总股本的比例为0.76%，回购的最高价为人民币24.03元/股，回购 的最低价为人民币19.58元/股，回购的资金总额为人民币111,559,033.92元（不含交易费用）。 ...

证券代码：603360 证券简称：百傲化学 公告编号：2025-069 大连百傲化学股份有限公司 关于以集中竞价方式回购股份的进展公告 大连百傲化学股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召开的 第五届董事会第十二次会议，审议通过了《关于以集中竞价交易方式回购公司股 份方案的议案》，同意公司以自有或自筹资金通过集中竞价交易方式回购公司股份， 用于员工持股计划或股权激励。回购股份价格为不超过人民币 44.94 元/股；回购 股份的资金总额不低于人民币 20,000 万元（含），不超过人民币 40,000 万元（含）； 回购期限为自公司董事会审议通过本次回购股份方案之日起 12 个月内。 因公司实施 2024 年年度权益分派，本次回购股份方案的回购股份价格上限由 不超过人民币 44.94 元/股调整为不超过人民币 31.67 元/股。 具体内容详见公司分别于 2025 年 4 月 25 日、2025 年 6 月 5 日在上海证券交 易所网站（www.sse.com.cn）及《中国证券报》《上海证券报》《证券日报》《证券 时报》披露的《大连百傲化学股份有限公司关于以集中竞价交易方式回购股份 ...

Company Overview - Baiao Chemical's stock price increased by 2.02% on September 3, reaching 25.79 CNY per share, with a trading volume of 262 million CNY and a turnover rate of 1.46%, resulting in a total market capitalization of 18.214 billion CNY [1] - The company specializes in the research, production, and sales of isothiazolinone-based industrial biocides, with domestic business accounting for 66.61% and international business for 33.39% of its revenue [1] Financial Performance - For the first half of 2025, Baiao Chemical reported a revenue of 749 million CNY, representing a year-on-year growth of 28.42%, while the net profit attributable to shareholders decreased by 44.22% to 91.7885 million CNY [2] - Since its A-share listing, Baiao Chemical has distributed a total of 1.224 billion CNY in dividends, with 722 million CNY distributed over the past three years [3] Shareholder Information - As of June 30, 2025, the number of Baiao Chemical's shareholders increased by 20.58% to 21,300, with an average of 33,173 circulating shares per shareholder, up by 16.11% [2] - Notable new institutional shareholders include the Southern CSI 1000 ETF, holding 3.2711 million shares, and Hong Kong Central Clearing Limited, holding 2.4283 million shares [3] Stock Performance - Baiao Chemical's stock has seen a year-to-date increase of 66.77%, with a 5-day increase of 8.82%, a 20-day increase of 24.65%, and a 60-day increase of 29.47% [1] - The company has appeared on the stock market's "Dragon and Tiger List" three times this year, with the most recent appearance on August 28 [1]

Group 1 - The company Baiao Chemical (603360) announced a share buyback program on the evening of September 2, stating that as of August 31, 2025, it has repurchased a total of 5,170,500 shares through centralized bidding [1] - The repurchased shares account for 0.73% of the company's total share capital [1]

New Stock Issuance - Fushun Special Steel (600399) has a tender offer period from August 12, 2025, to September 10, 2025[1] - KaiPu Cloud (688228) reported severe abnormal fluctuations on August 30, 2025[1] - Xinhua Jin (600735) announced on August 30, 2025, regarding its stock activities[1] Trading Alerts - JiShi Media (601929) issued a notice on August 30, 2025, regarding trading activities[1] - XianDao Intelligent (300450) and DeChuang Environmental (603177) both reported updates on September 2, 2025[1] - Huahai Pharmaceutical (600521) and *ST HuiCheng (002168) also provided trading updates on September 2, 2025[1] Abnormal Fluctuations - Several companies, including Changjiang Materials (001296) and WanBangDe (002082), reported abnormal fluctuations on August 28, 2025[3] - Longjing Technology (301396) and Jinli Yongci (300748) also noted significant trading irregularities on August 27, 2025[3] - The report includes multiple links to announcements regarding trading activities and fluctuations for various companies[3]